Using transgenic plants and modified plant viruses for the development of treatments for human diseases

•Concept of plant-based biofactories for therapeutics and biologics.•Industrial preference of transient expression system - agroinfiltration.•Advancement of virus-like particles from epitope presentation to nanomedicine.•Recent progress of plant-made therapeutics and biologics against human diseases.

Production of proteins in plants for human health applications has become an attractive strategy attributed by their potentials for low-cost production, increased safety due to the lack of human or animal pathogens, scalability and ability to produce complex proteins. A major milestone for plant-based protein production for use in human health was achieved when Protalix BioTherapeutics produced taliglucerase alfa (Elelyso®) in suspension cultures of a transgenic carrot cell line for the treatment of patients with Gaucher's disease, was approved by the USA Food and Drug Administration in 2012. In this review, we are highlighting various approaches for plant-based production of proteins and recent progress in the development of plant-made therapeutics and biologics for the prevention and treatment of human diseases.

Graphical abstractDownload high-res image (146KB)Download full-size image